Health Medical Pharma

Junk food increase ovarian, brain cancer risk: UK study

Fizzy drinks, mass-produced breads, many ready meals, and most breakfast cereals increase the risk of cancer as they contain higher salt, fat, sugar.

Read More
Drugs Medical Pharma

12 African nations commit to end AIDS in children by 2030

Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.

Read More
Drugs Medical Pharma

China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark

Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.

Read More
Climate Health Medical

FAO to implement new framework for risk management

A new Framework for Environmental and Social Management was unveiled by the Food and Agriculture Organisation to ensure agrifood systems adhere to global.

Read More
Health Medical Pharma

U.S. to end Covid-19 curbs on May 11, migrant policy remains same

The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.

Read More
Drugs Medical Pharma

Lupin gets tentative nod for three HIV drugs

Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its.

Read More
Drugs Medical Pharma

No ‘directed evolution research’ in COVID-19 vaccine: Pfizer

Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed.

Read More
Drugs Medical Pharma

COVID-19 to continue as public health emergency of international concern

COVID-19 will remain a pandemic as it continues to constitute a public health emergency of international concern, the WHO’s highest form of an.

Read More
Drugs Medical Pharma

Indian diagnostic firm Dr. Lal PathLabs acquires 10% of subsidiary

PathLabs Unifiers, a subsidiary of diagnostic services company Dr. Lal PathLabs, has acquired a 10% stake in one of its business units, APRL.

Read More
Drugs Medical Pharma

Sun Pharma buys three anti-inflammatory drug brands from Aksigen

Sun Pharmaceuticals announced it had acquired three brands from Aksigen to treat postoperative inflammation in patients undergoing minor surgery and dental procedures.

Read More